Phys Written Answers · gastrointestinal
Functional GI Disorders — Written Clinical Reasoning
DCE-style written reasoning for disorders of gut-brain interaction: a positive diagnosis of IBS with a stepped treatment plan, and functional dyspepsia work-up and treatment, from the BSG guidelines.
2 min readSource-verified ·
On this page
Study tools
Target exams
FRACP DCEMRCP Part 2
Prompt
DCE-style written reasoning for disorders of gut-brain interaction: a positive diagnosis of IBS with a stepped treatment plan, and functional dyspepsia work-up and treatment, from the BSG guidelines.
SAQ 1 — Irritable bowel syndrome (12 marks)
Prompt: A 30-year-old woman has eight months of recurrent lower abdominal pain, about twice a week, related to defecation, with mostly loose stools and bloating. There are no alarm features. Outline your diagnosis, investigations and stepped management. [1]
Model Answer
Diagnosis (3 marks):
- Rome IV IBS is recurrent abdominal pain associated with defecation or a change in bowel habits, with onset at least 6 months before diagnosis and symptoms present during the last 3 months. [3]
- IBS-D means more than 25 percent of bowel movements are Bristol type 6 or 7. [3]
- Make a positive diagnosis from symptoms, in the absence of alarm symptoms or signs and of abnormalities on simple blood and stool tests. [1]
Investigations (3 marks):
- Full blood count, CRP or ESR, coeliac serology and, because she is under 45 with diarrhoea, faecal calprotectin to exclude inflammatory bowel disease. [1]
- No breath testing for bacterial overgrowth or carbohydrate intolerance, and no pancreatic testing, in typical IBS. [1]
First-line management (3 marks):
- Explain the diagnosis and the gut-brain axis; advise regular exercise and first-line dietary advice. [1]
- Soluble fibre such as ispaghula, starting at 3 to 4 g/day; avoid insoluble fibre such as wheat bran. Loperamide may help diarrhoea, titrated carefully. [1]
Second-line (3 marks):
- A low-FODMAP diet supervised by a trained dietitian, with reintroduction according to tolerance. [1]
- A tricyclic antidepressant as a gut-brain neuromodulator, starting at amitriptyline 10 mg once daily and titrating to a maximum of 30 to 50 mg once daily. [1]
- In secondary care, 5-HT3 antagonists, rifaximin or eluxadoline are efficacious second-line drugs for IBS-D. [1]
- IBS-specific CBT or gut-directed hypnotherapy if symptoms have not improved after 12 months of drug treatment, or earlier if accessible. [1]
References5ShowHide
- [1]Vasant DH, Paine PA, Black CJ, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut, 2021.PMID 33903147
- [2]Black CJ, Paine PA, Agrawal A, et al. British Society of Gastroenterology guidelines on the management of functional dyspepsia. Gut, 2022.PMID 35798375
- [3]Lacy BE, Patel NK Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. Journal of clinical medicine, 2017.PMID 29072609
- [4]Black CJ, Staudacher HM, Ford AC Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut, 2022.PMID 34376515
- [5]Bertin L, Zanconato M, Crepaldi M, et al. The Role of the FODMAP Diet in IBS. Nutrients, 2024.PMID 38337655